Skip to main content navigation
Site logo
[n]
Local Navigation
Not signed in
Sign in

Powered by Sitebuilder
© MMVIII  |  Privacy

Nanotechnology and the Health of the EU Citizen in 2020 - Transcript

[c]

00:00            Molecules and atoms in an eye mixing through to a close-up of an eye
                      Low angle of delegates walking into Auditorium
                      Wide shot of auditorium
                      Close up of Ottilia Saxl

Guide Voice: NanoTechnology deals in the minute, at the levels of atoms and molecules. But its impact on our lives will be anything but small.

At least that was the feelings of around 1,500 of the world’s leading researchers, healthcare specialists and policy makers who attended EuroNanoForum 2005 in Edinburgh.

00:21 SOT: Ottilia Saxl; CEO Institute of Nanotechnology“My vision is that NanoTechnology in terms of the future will be like something out of Star Trek. It will be non-evasive. People will have sensors on you. You can sit in your own home. Your health details will be translated by the sensor. It will go to a central computer, it will tell you what’s wrong with you. I don’t see why we need the doctors in the middle we’ll need surgeons. Health care and monitoring should be as painless as possible and NanoTechnology is leading to that."

00:49            Shots of NanoTechnology being used
                      Close-up of Dr Octavio Quintana Trias
                      Close-up of delegates in audience
                      Wide shot Dr Octavio Quintana Trias

Guide Voice Heralding a revolution in health care, NanoTechnology research provides molecular-sized solutions to some of the most pressing medical problems.

And the European Commission has put its weight firmly behind the field, launching a new European Technology Platform on NanoMedicine at the conference. The commission proposes to double its funding from around 5 Billion Euros a year to 10 Billion.

01:15 SOT: Dr Octavio Quintana Trias; Director of Health, Research Directorate – General, European Commission – “It is true that in Europe we are leading in public investment on NanoTechnology and one of the biggest fields for application of it is certainly health. We have just seen that there are many, many applications that will change how health care is delivered how health care is provided and centred around the patient.”

01:45            Wide shots of Exhibition stands at EuroNanoFroum 2005
                      Close-up of arteries
                      Wide shot of speaker
                      Wide shot of auditorium
                      Close-up of delegates in audience
                      Close-up of auditorium screen with a hospital of the future on it

Guide Voice: NanoTechnology provides some of the most exciting areas of research. NanoDiagnosis is now sensitive enough to look at the working of the body and disease at the level of a single cell.

It can also improve existing therapies and invent novel ones for diseases which cannot be treated at present such as certain types of cancer, AIDS, Alzheimer’s, Parkinson’s and diabetes. The Commission’s aim is to drastically improve the EU citizen’s health by 2020 through NanoMedicine.

02:17 SOT: Dr Patrick Boisseau; Nano2Life, CEA-Leti – “The way we treat people will be significantly different. But we need to make a huge investment in research and understanding how these micronanotechnology could bring real improvements this is what we are focusing our efforts on.”

02:34 SOT: Jouko Karvinen; President & CEO, Philips Medical Systems – “The promise of success for nanomedicine, molecular medicine is that we can actually diagnose before symptoms. Nowadays as you well know you go to see the doctor when you have symptoms this is in vitro, outside the body, testing. You can be diagnosed before you even know you have a problem and the earlier you’re diagnosed and have treatment the better your life is going to be.”

03:05            Wide shot of auditorium
                      Close-up of delegates in audience
                      Mid-shot of Andreas Jordan

Guide Voice: NanoMedicine is already touching people’s lives however with Magforce NanoTechnologies in Germany enjoying success in defeating cancer through NanoTechnology.

03:16 SOT: Andreas Jordan; Managing Director MagForce Nanotechnologies – “We think that with this technology we can give the patients a second chance to survive. Our clinical studies, I think we have good signs that we have some long term survivors which had a very short life expectancy.”

03:32            Shots of NanoTechnology being used.
                      Shots of researchers in lab.

Guide Voice: If it wasn’t for companies like MagForce the wonders of NanoTechnology would just be a pipe dream. The future health of the world’s population is in their hands.

03:43 SOT: Dr Alessandra Pavesio; Director of Research & Development, Fidia Advanced Biopolymers – “So really the responsibility for this translation of research from academia to industry is of the SME which is also where Europe has a leading role. If we’re good at something we’re good at SMEs we’re good at small entrepreneurial structures and developing and taking research through to industry.”

04:06            Wide shot of press conference.
                      Close-up of Andreas Jordan
                      Close-up of Dr Alessandra Pavesio
                      Close-up of  Dr Patrick Boisseau
                      Wide shot of schoolchildren watching presentation
                      Close-ups of kids
                      Wide shot of schoolchildren watching presentation

Guide Voice: EuroNanoForum 2005 was attended by some of the brightest brains in the world. But arguably the most important people at the conference were a group of Edinburgh schoolchildren, there for an introduction to NanoTechnology. They are the next generation of researchers, policy makers and health care specialists who will decide how NanoTechnology is used in the future.

04:33   End

This material is available for use without restriction for up to 28 days after the feed date, Thursday 8 September 2005. For use beyond this period, please contact Research-TV on 44 (0) 20 7004 7130 or email enquiries@research-tv.com.

Page contact: Shuehyen Wong Last revised: Thu 8 Sep 2005
Back to top of page